Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification and validation of molecular subtypes and a 9-gene risk model for breast cancer.

Medicine - 22 Sept 2023

Feng Jiexin

Abstract excerpt

The long-term efficacy of treatment, heterogeneity, and complexity in the tumor microenvironment remained a clinical challenge in breast cancer (BRCA). There is a need to classify and refine appropriate therapeutic intervention decisions. A stable subtype classification based on gene expression associated with neoadjuvant chemotherapy (NAC) prognosis and assessment on the clinical features, immune infiltration,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Mutation
Share to Neoadjuvant Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Nuclear Proteins

Share to Tumor Microenvironment

Source

Open in PubMed Open full text

Identifiers

PMID: 37747033
DOI: 10.1097/MD.0000000000035204
PMCID: PMC10519538

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification and validation of molecular subtypes and a 9-gene risk model for breast cancer.PMID 37747033Read ↗

Identification of a novel immune-related gene signature by single-cell and bulk sequencing for the prediction of the immune landscape and prognosis of breast cancerSemantic proximity Read ↗

Prognostic Analysis of Patients with Breast Cancer Based on Tumor Mutational Burden, DNA Damage Repair Genes, and Immune InfiltrationSemantic proximity Read ↗

Identification of necroptosis-related subtypes and prognosis model in triple negative breast cancerSemantic proximity Read ↗

CDKN2A-mediated molecular subtypes characterize the hallmarks of tumor microenvironment and guide precision medicine in triple-negative breast cancerSemantic proximity Read ↗

Identification and validation of a novel prognostic signature with DNA methylation-driven genes for survival prediction of breast cancerSemantic proximity Read ↗

Immune-related gene data-based molecular subtyping related to the prognosis of breast cancer patients.Semantic proximity Read ↗

Construction and Validation of Immune-Related LncRNA Signature to Predict the Prognosis and Therapeutic Efficacy of Breast CancerSemantic proximity Read ↗

Identification of an immune cell infiltration-related gene signature for prognosis prediction in triple-negative breast cancer.Semantic proximity Read ↗

Identification of Breast Cancer Subtypes by Integrating Genomic Analysis with the Immune MicroenvironmentSemantic proximity Read ↗

Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Estrogen Receptor (ER) or Progesterone Receptor (PR) Positive and Human Epidermal Growth Factor Receptor 2 (HER2) Negative Breast CancerSemantic proximity Read ↗

Combination of Immune-Related Network and Subtype-Specific Analysis Define a Three- Gene Panel for Predicting Prognosis of Triple-Negative Breast CancerSemantic proximity Read ↗

A Novel Immune Checkpoint-Related Gene Signature to Predict Overall Survival and Immunotherapy Response in Triple-Negative Breast CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.